Staphylococcus aureus is a common hospital and household pathogen. Given the
emergence of antibiotic-resistant derivatives of this pathogen resulting from the use of …

Skin barrier defects play an important role in atopic dermatitis (AD) pathogenesis. Loricrin,
an important barrier protein suppressed in human AD, is down-regulated by IL-4 in …

The aim of this study was to conduct 3 literature reviews to examine the impact of atopic
dermatitis (AD) and chronic hand eczema (CHE) on health-related quality of life (HRQoL) …

Purpose: This is a review of emerging targeted, systemic therapies for atopic dermatitis (AD).
The information presented aims to provide dermatologists with updated therapeutic options …

Atopic dermatitis (AD) is a chronic inflammatory skin disease that affects up to 25% of
children and 10% of adults. The skin of patients with moderate to severe AD is characterized …

IgE‐associated allergic diseases belong to the most common inflammatory conditions. Their
clinical manifestation ranges from mild symptoms to life‐threatening episodes. Often patients …

In atopic dermatitis (AD), the skin inflammation is believed to occur due to a misdirected
immune reaction against harmless antigens on the one hand, and to a disturbed skin barrier …

Atopic dermatitis (AD) is the most common chronic inflammatory skin disorder of childhood.
Underlying factors that contribute to AD are impaired epithelial barrier, alterations in the lipid …

Atopic dermatitis (AD) is a common allergic skin disease that is associated with chronic,
recurrent eczematous and pruritic lesions at the flexural folds caused by interacting factors …

Current novel approaches in systemic therapy of atopic derma... : Current Opinion in Allergy
and Clinical Immunology Current novel approaches in systemic therapy of atopic dermatitis …